1. M17 Targeting Dopamine D1-histamine H3 Receptor Heteromers As A Therapeutical Strategy To Prevent Cognitive Deficits And Neurodegeneration In Huntington's Disease. (17th September 2014) Authors: Cañadell, MP; Moreno-Delgado, D; Rodríguez-Ruiz, M; Moreno, E; Botta, J; Gasperini, P; Cordomí, A; Howell, LA; Navarro, G; Casadó, V; Ferré, S; Guzmán, M; Pardo, L; Alberch, J; Canela, EI; Lluís, C; McCormick, P J; Ginés, S Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 85(2014)Supplement 1 Page Start: A100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗